Review



customized mirna array panel  (Qiagen)


Bioz Verified Symbol Qiagen is a verified supplier
Bioz Manufacturer Symbol Qiagen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    Qiagen customized mirna array panel
    miR <t>expression</t> <t>profiles</t> in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of <t>miRNA.</t> Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.
    Customized Mirna Array Panel, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 3282 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customized+mirna+array+panel/pmc12464475-151-10-17?v=Qiagen
    Average 99 stars, based on 3282 article reviews
    customized mirna array panel - by Bioz Stars, 2026-07
    99/100 stars

    Images

    1) Product Images from "Association between miRNA expression profiles and polymorphisms of dihydropyrimidine dehydrogenase drug-metabolizing gene in patients with colorectal cancer receiving 5-fluorouracil"

    Article Title: Association between miRNA expression profiles and polymorphisms of dihydropyrimidine dehydrogenase drug-metabolizing gene in patients with colorectal cancer receiving 5-fluorouracil

    Journal: Biomedical Reports

    doi: 10.3892/br.2025.2053

    miR expression profiles in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.
    Figure Legend Snippet: miR expression profiles in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.

    Techniques Used: Expressing, Clinical Proteomics, Quantitative Proteomics, Variant Assay

    miRNA expression profiles in patients with VT ( DPYD 1896T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with (n=3) and WT colorectal cancer (n=3). (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; snRNA, small nuclear RNA.
    Figure Legend Snippet: miRNA expression profiles in patients with VT ( DPYD 1896T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with (n=3) and WT colorectal cancer (n=3). (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; snRNA, small nuclear RNA.

    Techniques Used: Expressing, Clinical Proteomics, Quantitative Proteomics, Variant Assay



    Similar Products

    customized mirna array panel  (Qiagen)
    99
    Qiagen customized mirna array panel
    miR <t>expression</t> <t>profiles</t> in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of <t>miRNA.</t> Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.
    Customized Mirna Array Panel, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/customized+mirna+array+panel/pmc12464475-151-10-17?v=Qiagen
    Average 99 stars, based on 1 article reviews
    customized mirna array panel - by Bioz Stars, 2026-07
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    miR expression profiles in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.

    Journal: Biomedical Reports

    Article Title: Association between miRNA expression profiles and polymorphisms of dihydropyrimidine dehydrogenase drug-metabolizing gene in patients with colorectal cancer receiving 5-fluorouracil

    doi: 10.3892/br.2025.2053

    Figure Lengend Snippet: miR expression profiles in patients with VT ( DPYD 85T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with VT (n=4) and WT colorectal cancer (n=5) using miR array. (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; sn, small nuclear.

    Article Snippet: The miRNA expression profiles were analyzed using RT-PCR with a customized miRNA array panel (cat. no. 217184; Qiagen GmbH) coated with specific primers for 43 miRNAs (sequences not provided) involved in the 5-FU metabolic pathway. miR target sequences are listed in .

    Techniques: Expressing, Clinical Proteomics, Quantitative Proteomics, Variant Assay

    miRNA expression profiles in patients with VT ( DPYD 1896T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with (n=3) and WT colorectal cancer (n=3). (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; snRNA, small nuclear RNA.

    Journal: Biomedical Reports

    Article Title: Association between miRNA expression profiles and polymorphisms of dihydropyrimidine dehydrogenase drug-metabolizing gene in patients with colorectal cancer receiving 5-fluorouracil

    doi: 10.3892/br.2025.2053

    Figure Lengend Snippet: miRNA expression profiles in patients with VT ( DPYD 1896T>C) and WT colorectal cancer. A total of 43 miRs were detected in the plasma of patients with (n=3) and WT colorectal cancer (n=3). (A) Heat map of differential expression of miRs in VT compared with WT colorectal cancer. Red and green show up- and downregulation, respectively. (B) Scatter plot showing miR profiles between VT and WT colorectal cancer. Each dot represents the fold-change in expression of miRNA. Red, green, and black dots represent up- and downregulated and unchanged miRNAs, respectively. miR, microRNA; VT, Variant; DPYD , dihydropyrimidine dehydrogenase gene; WT, Wild type; min, minimum; avg, average; max, maximum; snRNA, small nuclear RNA.

    Article Snippet: The miRNA expression profiles were analyzed using RT-PCR with a customized miRNA array panel (cat. no. 217184; Qiagen GmbH) coated with specific primers for 43 miRNAs (sequences not provided) involved in the 5-FU metabolic pathway. miR target sequences are listed in .

    Techniques: Expressing, Clinical Proteomics, Quantitative Proteomics, Variant Assay